77 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights ans shares making of the share capital - november

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		08/12/2022 Voting rights

Buyback programs - november 2022

Monthly communication regarding buyback programs

 		08/12/2022 Description of buyback programs

Monthly communication regarding buyback programs - october 2022

 		10/11/2022 Voting rights

Buyback programs - october 2022

Monthly communication regarding buyback programs

 		10/11/2022 Description of buyback programs

First nine months 2022 sales: €405M

In line with year-end outlook

 		12/10/2022 Public releases

Monthly communication regarding buyback programs - September 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		05/10/2022 Voting rights

Buyback programs - september 2022

Monthly communication regarding buyback programs

 		05/10/2022 Description of buyback programs

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

 		23/09/2022 Public releases , Half Year Report

2022 half-year results

This document has been prepared by Vetoquinol for the sole purpose of presenting the half-year results for the fiscal year 2022, on September 15, 2022.

 		15/09/2022 Half Year Report

2022 HALF YEAR RESULTS

Sales: €271m (up 6.0% as reported)
Essentials sales: €154m (up 9.8% as reported)
EBIT before depreciation of acquired assets: €52m (19.0% of sales)
Net income - Group share: €21m (7.9% of sales)
EBITDA: €62m (22.9% of sales)

 		15/09/2022 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2022

As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		06/09/2022 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - July 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		22/08/2022 Voting rights

H1 2022 Sales

H1 2022 Sales: €271m, up 6.1%
+2.0% on a like-for-like basis
H1 2022 Essentials Sales: €154m, up 9.8%
+6.8% on a like-for-like basis

 		20/07/2022 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - june 2022

as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		05/07/2022 Voting rights

Buyback programs - may 2022

Monthly communication regarding buyback programs

 		03/06/2022 Monthly communication regarding buyback programs

Monthly information regarding the total number of voting rights and shares making of the share capital - may 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		03/06/2022 Voting rights

Remuneration vote results - AG may 2022

 		20/05/2022 Shareholders´s Meeting

Vote results - AG may 19, 2022

 		20/05/2022 Shareholders´s Meeting

Information regarding the total number of voting rights and shares making of the share capital - 12 may 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		13/05/2022 Shareholders´s Meeting

Monthly information regarding the total number of voting rights and shares making of the share capital - april 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers»

 		05/05/2022 Voting rights

Buyback programs - april 2022

Monthly communication regarding buyback programs

 		05/05/2022 Monthly communication regarding buyback programs

Universal registration document 2021

Universal Registration Document including the Annual Financial Report

 		05/05/2022 Reference document

Balo new information

Balo new information

 		05/05/2022 Shareholders´s Meeting

Number of voting rights and shares making of the share capital

Information regarding the total number of voting rights and shares making of the share capital  - J-21 before AGM as per articles L233-8-II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		03/05/2022 Shareholders´s Meeting

Annual general meeting 2022 - brochure

 		28/04/2022 Shareholders´s Meeting

Availability of the 2021 universal registration document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

 		22/04/2022 Public releases

Vote by post / proxy form

Vote by post of proxy form for annual general meeting on May 19, 2022

 		19/04/2022 Shareholders´s Meeting

General annual meeting - may 19 2022

Annual General Meeting on May 19, 2022 - convocation

 		19/04/2022 Shareholders´s Meeting

Q1 2022 SALES: €135M

Q1 2022 SALES: €135M
(UP 5.5% AS REPORTED, UP 2.2% AT CONSTANT EXCHANGE RATES)
Q1 2022 ESSENTIALS SALES: €77M
(UP 8.1% AS REPORTED, UP 5.5 AT CONSTANT EXCHANGE RATES)

 		13/04/2022 Public releases

Buyback programs - march 2022

Monthly communication regarding buyback programs

 		06/04/2022 Monthly communication regarding buyback programs

Monthly information regarding the total number of voting rights and shares - march 2022

Monthly information regarding the total number of voting rights and shares making of the share capital

as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		06/04/2022 Voting rights

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

 		24/03/2022 Public releases

Annual results 2021 (slideshow)

This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022.

 		24/03/2022 Annual Report

[AUDIO] Présentation des résultats 2021

Présentation analystes & investisseurs - 24 mars 2022

 		24/03/2022 Annual Report

Monthly information regarding the total number of voting rights and shares making of the share capital- february 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		04/03/2022 Voting rights

Buyback programs - february 2022

Buyback programs - February 2022

 		04/03/2022 Monthly communication regarding buyback programs

Buyback programs - January 2022

 		07/02/2022 Monthly communication regarding buyback programs

Double-digit growth in 2021

Total Group Sales: €521 million (up 21.9% as reported)
Annual Sale of Essential products: €296 million (up 34.0% as reported)

 		20/01/2022 Public releases

Clone of Monthly information regarding the total number of voting rights and shares making of the share capital

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		06/01/2022 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

 		06/01/2022 Voting rights

Programme de rachat - Décembre 2021

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres.

 		04/01/2022 Monthly communication regarding buyback programs

Bilan annuel des moyens alloués au contrat de liquidité (décembre 2021)

Au titre du contrat de liquidité confié par la Société VETOQUINOL à la Société ODDO CORPORATE FINANCE, les moyens suivants figuraient au compte de liquidité au 31 décembre 2021

 		04/01/2022 Liquidity contract

Vétoquinol announces opening of its first decentralized R&D center in Canada

 		17/12/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

 		12/12/2007 Voting rights

2008 calendar of financial communication

 		10/12/2007 Agenda

Rapport du président sur le fonctionnement du conseil d’administration et sur le contrôle des procédures internes

En application de l’article L. 225-37 du Code de commerce, Monsieur Etienne Frechin, Président-Directeur Général du Groupe Vétoquinol, rend compte dans le cadre du présent rapport « des conditions de préparation et d’organisation des travaux du conseil ainsi que des procédures de contrôle interne mises en place par la société ».
Le présent rapport concerne la société-mère et l’ensemble des sociétés du Groupe entrant dans le périmètre de consolidation.

 		05/12/2007 Report on internal control and corporate governance

Vétoquinol to market and distribute Vetprofen in the United States

 		28/11/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

 		15/11/2007 Voting rights

3rd quarter revenues confirm promise of
strong growth prospects for 2007

For the nine months ended September 30, 2007, Vétoquinol’s total revenues reached €166.0 M, an increase of 11.3% compared with the
corresponding period in 2006.

 		25/10/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

 		08/10/2007 Voting rights

Etats financiers consolidés du 1er semestre 2007 (french)

 		27/09/2007 Half Year Report

Reports very good first half, confirming that 2007 performance is set to surpass targets

 		27/09/2007 Public releases

Presentation of Vétoquinol’s results for the first half of 2007

2007 Half year results

 		27/09/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital.

 		06/09/2007 Voting rights

Rapport semestriel 2007 « narratif » (french)

Suite à la publication du 26 juillet dernier, Vétoquinol a réalisé au 1er semestre 2007 un
chiffre d’affaires de 111,1 M€ contre 98,4 M€ au cours de la même période de l’exercice
précédent, soit une progression de 12,9 %.
A cours de change et périmètre constants, la progression est de 10,1 %.

 		31/08/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital.

 		03/08/2007 Voting rights

Business is strong in first-half of 2007 : + 12.9%

2007 Half year Financial Report

 		26/07/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital.

 		10/07/2007 Voting rights

Bilan semestriel des moyens alloués au contrat de liquidité (2007) - french

Au 30 juin 2007

 		06/07/2007 Liquidity contract

Vétoquinol creates a subsidiary in Portugal

 		05/07/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital.

 		08/06/2007 Voting rights

2006 Financial Report

Le chiffre d’affaires s’est accru de 7,6% par rapport à l’exercice précédent.
Le résultat opérationnel courant, qui s’élève à 25,6 M€, est en augmentation de 10,8%.
Enfin, le résultat net de 15,8 M€ progresse de 27,2% et représente 7,5% du chiffre d’affaires.
Cette croissance a été maîtrisée et équilibrée.

 		04/06/2007 Public releases

Activity Report 2006

 		04/06/2007 Public releases

Annual general meeting of the shareholders

 		04/06/2007 Shareholders´s Meeting

Etats financiers consolidés au 31 décembre 2006 (french)

 		10/05/2007 Annual Report

Rapport annuel 2006 (french)

 		10/05/2007

Monthly information regarding the total number of voting rights and shares making of the share capital

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		10/05/2007 Voting rights

Convocations : assemblées d'actionnaires et de porteurs de parts (french)

 		27/04/2007 Shareholders´s Meeting

Annual earnings for 2006: a year of good performance

23/04/2007 Public releases

Présentation des résultats 2006 de Vétoquinol (french)

 		23/04/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

10/04/2007 Voting rights

Vétoquinol reports one of its industry’ strongest growth performances in 2006

 		03/04/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

12/03/2007 Voting rights

Sustained revenue growth in 2006

 		15/02/2007 Public releases

Rapport complémentaire du conseil d'administration sur l'utilisation de la délégation de compétence relative à l'augmentation de capital réservée aux salariés adhérents au PEE - conseil d'administration du 16 novembre 2006 (french)

01/02/2007

Rapport complémentaire du conseil d'administration sur l'utilisation des délégations de compétence - conseil d'administration du 8 décembre 2006 (french)

01/02/2007

Vétoquinol strengthens its position in the United States

 		02/01/2007 Public releases